Sign in

CIK 0001812364

  • Large accelerated filer

Relay Therapeutics, Inc.

Sign in to watch
Ticker
RLAY
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-370-8837
Business address
60 HAMPSHIRE STREET, CAMBRIDGE, MA, 02139
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Open-market sale See remarks sold 12,103 shares at an average $3.02 ($36,541)
  7. 4 Planned sale Chief Financial Officer sold 19,191 shares at an average $3.07 ($58,849)
  8. 4 Open-market sale President, R&D sold 31,562 shares at an average $3.02 ($95,381)
  9. 4 Open-market sale Chief Legal Officer sold 14,587 shares at an average $3.02 ($44,040)
  10. 4 Open-market sale President and CEO sold 61,422 shares at $2.97 ($182,423)
  11. 4 Open-market sale President, R&D sold 986 shares at $2.84 ($2,800)
  12. 4 Open-market sale See remarks sold 247 shares at $2.84 ($701)
  13. 4 Planned sale Chief Financial Officer sold 4,864 shares at $2.84 ($13,814)
  14. 4 Open-market sale Chief Legal Officer sold 298 shares at $2.84 ($846)
  15. 4 Open-market sale President and CEO sold 215,506 shares at an average $3.80 ($818,400)
  16. 4 Open-market sale See remarks sold 45,464 shares at an average $4.50 ($204,753)
  17. 4 Planned sale Chief Financial Officer sold 58,936 shares at an average $4.55 ($268,339)
  18. 4 Open-market sale President, R&D sold 80,450 shares at an average $4.50 ($362,298)
  19. 4 Open-market sale Chief Legal Officer sold 54,479 shares at an average $4.55 ($247,872)
  20. 4 Planned sale President and CEO sold 375,000 shares at an average $4.70 ($1,762,500)

Page 4 of 16 · 320 filings